CIK 0001787400 · Non-accelerated filer<br>Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474515206
- Phone
- (925) 407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-16 | Hager Alicia J. Chief Legal Officer | Sale | −4,554 | $8.74 | $40K | 107,942 |
| 2024-01-04 | Shook David Chief Medical Officer | Grant or award | +56,000 | 118,532 | ||
| 2024-01-04 | Shook David Chief Medical Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2024-01-04 | Brandenberger Ralph Chief Technical Officer | Grant or award | +56,000 | 84,088 | ||
| 2024-01-04 | Brandenberger Ralph Chief Technical Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2024-01-04 | Trager James Chief Scientific Officer | Grant or award | +56,000 | 158,118 | ||
| 2024-01-04 | Trager James Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2024-01-04 | HASTINGS PAUL J Chief Executive Officer | Grant or award | +85,000 | 400,204 | ||
| 2024-01-04 | HASTINGS PAUL J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +509,500 | 509,500 | ||
| 2024-01-04 | Levin Alyssa See Remarks | Grant or award | +56,000 | 56,000 | ||
| 2024-01-04 | Levin Alyssa See Remarks | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2024-01-04 | Hager Alicia J. Chief Legal Officer | Grant or award | +56,000 | 112,496 | ||
| 2024-01-04 | Hager Alicia J. Chief Legal Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2023-08-21 | Shook David Chief Medical Officer | Sale | −1,331 | $1.83 | $2K | 60,532 |
| 2023-07-01 | Levin Alyssa See Remarks | Grant or award · Stock Option (right to buy) | +442,400 | 442,400 | ||
| 2023-07-01 | Shook David Chief Medical Officer | Grant or award · Stock Option (right to buy) | +208,000 | 208,000 | ||
| 2023-06-20 | Trager James Chief Scientific Officer | Sale | −439 | $4.85 | $2K | 100,118 |
| 2023-06-20 | Brandenberger Ralph Chief Technical Officer | Sale | −221 | $4.85 | $1K | 28,088 |
| 2023-06-20 | Hager Alicia J. Chief Legal Officer | Sale | −701 | $4.85 | $3K | 56,496 |
| 2023-06-20 | Shook David Chief Medical Officer | Sale | −439 | $4.85 | $2K | 61,863 |
Page 5 of 8 · 159 trades